Work

A phase I study of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in patients with advanced solid malignancies

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.3054

Authors: C. P. Lee, G. Attard, L. Poupard, P. D. Nathan, J. S. de Bono, G. M. R. Temple, M. F. Stefanic, A. R. Padhani, I. R. Judson, G. J. Rustin

Institution: Royal Marsden Hospital

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2332331891

Cites:

Cited by: 15

Related to: 10